Search Results for 'FDA'

Galway-based medical device company Nua Surgical has announced the closure of its €6.5 million funding round for its innovative SteriCISION® C-Section Retractor.

Parkmore-based VERSONO® Medical Ltd has begun enrolling patients in the FREEFLOW pivotal study for its FastWire System. FastWire is a truly disruptive technology designed to quickly access previously untreatable complex blockages in arteries, increasing success rates and reducing risk of amputations via endovascular techniques.

Parkmore-based VERSONO® Medical Ltd has begun enrolling patients in the FREEFLOW pivotal study for its FastWire System. FastWire is a truly disruptive technology designed to quickly access previously untreatable complex blockages in arteries, increasing success rates and reducing risk of amputations via endovascular techniques.

Chez Elaine, leaders of non-invasive face and body advanced aesthetic therapies, are delighted to announce their EMSUITE 'Open House Event' on Thursday, November 7, and Friday, November 8, a date for your diary that you don’t want to miss.

Ballybrit-based M & M Qualtech has been awarded an IQNET recognized certificate by the National Standards Authority of Ireland (NSAI) for its exceptional Quality Management System. This prestigious certification is in accordance with the I.S. EN ISO 9001:2015 standard, demonstrating the company's commitment to maintaining the highest levels of quality in its operations.

Ballybrit-based M & M Qualtech has been awarded an IQNET recognized certificate by the National Standards Authority of Ireland (NSAI) for its exceptional Quality Management System. This prestigious certification is in accordance with the I.S. EN ISO 9001:2015 standard, demonstrating the company’s commitment to maintaining the highest levels of quality in its operations.

Galway-based Signum Surgical — a medical technology company developing innovative solutions to treat colorectal diseases, has confirmed that its BioHealxTM technology has been granted marketing clearance by the U.S. Food and Drug Administration (FDA), as a first-of-its-kind medical device for the treatment of anal fistula.

One of Ireland’s most successful companies, Chanelle Pharma has been sold by its founder Michael H Burke to Exponent, a leading private equity firm. Headquartered in Loughrea, Chanelle Pharma is Ireland’s largest indigenous manufacturer of generic pharmaceuticals for animal and human health. The terms of the sale have not been disclosed.

Hyperbaric oxygenation (HBOT) has emerged as an extremely effective treatment for individuals experiencing post-radiation injuries, offering relief and healing for late-emerging symptoms. This treatment is FDA approved and medically advised for those suffering post radiation injuries.